Follow The Journey.

23-09-2024 : Began as just a series of wild thoughts tied together by a simple objective, to make diagnostics portable and cheap.

The first conceptual design was created.

06-02-2025 : After months of refining and scrapping through designs, the final design was made.

The design was optimised to use natural forces and not rely on any external assistance like pumps. This design is special in itself because it can manipulate fluids at microlitre scale with great precision.

15-02-2025 : The novel design for the chip was patented. The patent serves in companies' interest of holding an IP (Intellectual Property)

19-03-2025 : After making required shifts, a 3D model of the chip was printed to confirm and check for the movement of fluid in the channels of the chip.

The test was successful and further validated the chip's viability.

As of now, BioDiscAi's team is actively seeking investors to proceed into the next steps

The funds raised would be used appropriately to make the first completely functional device. This would serve as a milestone in this journey as most if not all the technical issues would be solved.

The device would be then tried and validated in clinical and lab settings to gain government approval.

Billions of diagnostic data set collected from across the world would be fed to BioDiscAi's advance AI system that would learn to detect subtle changes in biomarkers and point out any red flags concerning the user's health. The Ai's capabilities and abilities would keep increasing with every new test making it more than just a biomarker analyser, overtime it could predict diseases from subtle biomarker shift that would have been irrelevant to the human eyes.

With our Ai system up and running, our devices ready to be produced at scale, we would enter a new dawn of human development. With the GLOBAL LAUNCH of our device, we aim to increase life expectancy across globe and push for not just a longer life, but a healthier one

“We’re not just chasing the future — we’re building the tool that finds it first.”

The Future of Precision: CRISPR & Beyond

At the heart of our innovation is a promise: to always push the frontier of diagnostics forward. While our current Lab-on-a-Disc platform already enables rapid, accessible, and accurate testing for a wide range of diseases, our eyes are set on what’s next — and that begins with CRISPR.

Integrating CRISPR into Point-of-Care (PoC)
CRISPR-based diagnostics represent a groundbreaking shift in how we detect disease. With its ability to identify nucleic acids with incredible precision, CRISPR can enable ultra-sensitive detection of viral, bacterial, and even genetic conditions — all without the need for centralized labs or long wait times.

We are currently investing in research and development to miniaturize and automate CRISPR detection tools into our existing LoaD (Lab on a Disc) platform. Our goal is to make gene-based diagnostics not only mobile but also affordable — empowering clinicians and communities with the tools to diagnose rare mutations, identify new pathogens, and personalize treatments in real-time.

Genetic Monitoring for All

We believe that personalized medicine starts with personalized diagnostics. Our future LoaD platforms will be able to identify single nucleotide polymorphisms (SNPs) and gene markers, paving the way for:

1.Carrier screening

2.Hereditary cancer risk analysis

3.Pharmacogenomic compatibility

4.Preventive health profiling

This next-gen diagnostic system will help predict illness long before symptoms appear — transforming medicine from reactive to proactive.

A Global Pathogen Radar

By combining high-frequency testing with our AI backbone, we plan to transform our devices into a global early warning system. Imagine a world where the first signs of a pandemic are detected in real-time — with localized mutations tracked across geographies using anonymized test results. Our future infrastructure will feed global health data into an AI platform that can:

1.Detect emerging health threats

2.Identify epidemiological shifts

3.Predict health trends before they surface in hospitals

This is more than a diagnostic device — it's a public health sentinel.

Future Modules & Plug-Ins

We envision our device as a modular, evolving platform. Future upgrades will include:

1.CRISPR modules for pathogen and genetic testing

2.Hormone and fertility panels for reproductive health

3.Neurochemical biomarker detection for early signs of mental health conditions

4.At-home cancer recurrence monitoring

These expansions will ensure that your diagnostic device grows with you — serving a lifetime of care and adapting as science advances.